Search results
Biotech Crashes 65% After FDA Puts Diabetes Studies On Hold
Investor's Business Daily· 1 hour agoThe drug, BMF-291, was in early-stage testing for patients with type 1 and type 2 diabetes. The FDA...
Commonly Used Meds Tied to Lower Risk for Aneurysm Rupture
Medscape· 9 hours agoCommonly prescribed drugs are associated with lower risk for aneurysmal subarachnoid hemorrhage....
Diabetes biotech stock tanks as FDA imposes full clinical hold
FierceBiotech· 2 hours agodiabetes program over liver toxicity concerns. In preclinical tests, the molecule improved beta cell...
This Pharma Stock Dropped 60% Premarket As FDA Halted Diabetes Drug Trials - Biomea Fusion...
Benzinga· 4 hours agoWhat Happened: The FDA’s decision was driven by concerns over potential drug-induced hepatotoxicity...
FDA places full clinical hold on Biomea Fusion’s diabetes trials of BMF-219
Clinical Trials Arena via Yahoo Finance· 6 hours agoThe double-blind, placebo-controlled COVALENT-112 trial is designed to assess BMF-219 in 150 adults...
The disproportionate toll that COVID-19 took on people with diabetes continues today
Medical Xpress· 21 hours agoAt the start of the pandemic, many people living with diabetes were wondering what COVID-19 meant...
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 24 hours agoHowever, another drug designed to assist with type 2 diabetes treatment, metformin, had a 13-year...
Analysis | Weight-loss drugs are so popular they’re headed for Medicare negotiations
Washington Post· 2 hours agoToday’s edition: Conservative policymakers with ties to former president Donald Trump want to limit...
Weight loss medication complete guide: From Wegovy to Mounjaro
The Telegraph via Yahoo News· 2 days agoThe new generation of weight-loss drugs were initially developed to treat diabetes and work by...
Scotiabank cuts Biomea Fusion shares target, notes FDA clinical hold concerns By Investing.com
Investing.com· 2 hours ago(NASDAQ: BMEA) shares, reducing it to $21.00 from the previous $41.00. The adjustment follows the...